Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )
2.790
-0.060
(-2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023
March 28, 2024
Nasdaq Edges Lower; ContextLogic Shares Surge
February 12, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
February 12, 2024
US Stocks Mixed; Trimble Issues Weak Outlook
February 12, 2024
Why Is Infectious Disease-Focused AN2 Therapeutics Stock Sinking Today?
February 12, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 12, 2024
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 06, 2023
AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023
October 11, 2023
Top 5 Health Care Stocks That May Fall Off A Cliff
September 06, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
||||||||||||||||||||
|